European Journal of Surgical Oncology
Volume 35, Issue 12 , Pages 1306-1311 , December 2009

Neoadjuvant chemoradiation and pancreaticoduodenectomy for initially locally advanced head pancreatic adenocarcinoma

  • O. Turrini

      Affiliations

    • Department of Surgical Oncology, Institut Paoli-Calmettes and Université de la Méditerranée Marseille, France
    • Corresponding Author InformationCorrespondence at: O. Turrini, Institut Paoli-Calmettes, 232 Bd de Sainte Marguerite, 13009 Marseille, France. Tel.: +33 491 223660; fax: +33 491 223550.
    • ,
  • F. Viret

      Affiliations

    • Department of Medical Oncology, Institut Paoli-Calmettes and Université de la Méditerranée Marseille, France
    • ,
  • L. Moureau-Zabotto

      Affiliations

    • Department of Radiotherapy, Institut Paoli-Calmettes and Université de la Méditerranée Marseille, France
    • ,
  • J. Guiramand

      Affiliations

    • Department of Surgical Oncology, Institut Paoli-Calmettes and Université de la Méditerranée Marseille, France
    • ,
  • V. Moutardier

      Affiliations

    • Department of Surgical Oncology, Institut Paoli-Calmettes and Université de la Méditerranée Marseille, France
    • ,
  • B. Lelong

      Affiliations

    • Department of Surgical Oncology, Institut Paoli-Calmettes and Université de la Méditerranée Marseille, France
    • ,
  • M. Giovannini

      Affiliations

    • Department of Endoscopy, Institut Paoli-Calmettes and Université de la Méditerranée Marseille, France
    • ,
  • J.R. Delpero

      Affiliations

    • Department of Surgical Oncology, Institut Paoli-Calmettes and Université de la Méditerranée Marseille, France

,Accepted 8 June 2009.

References 

  1. Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007 Jan 17;297(3):267–277
  2. Evans DB For The Multidisciplinary Pancreatic Cancer Study Group. Resectable pancreatic cancer: the role for neoadjuvant/preoperative therapy. HPB (Oxford). 2006;8(5):365–368
  3. Varadhachary DR, Tamm EP, Abruzzese JL, et al. Borderline resectable pancreatic cancer: definitions, management and role of preoperative therapy. Ann Surg Oncol. 2006;13:1035–1046
  4. Talamonti M. Borderline resectable pancreatic cancer: a new classification for an old challenge. Ann Surg Oncol. 2006 Aug;13(8):1019–1020
  5. Sultana A, Smith CT, Cunningham D, et al. Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. Clin Oncol. 2007 Jun 20;25(18):2607–2615
  6. Haddock MG, Swaminathan R, Foster NR, et al. Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942. J Clin Oncol. 2007 Jun 20;25(18):2567–2572
  7. White RR, Reddy S, Tyler DS. The role of chemoradiation therapy in locally advanced pancreatic cancer. HPB (Oxford). 2005;7(2):109–113
  8. Ishikawa O, Ohigashi H, Imaoka S, et al. Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg. 1992;215:231–236
  9. Sasson AR, Hoffman JP, Ross EA, et al. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?. J Gastrointest Surg. 2002;6:147–158
  10. Tseng JF, Raut CP, Lee JE, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg. 2004;8:935–950
  11. Fuhrman GM, Leach SD, Staley CA, et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg. 1996;223:154–162
  12. Carrere N, Sauvanet A, Goere D, et al. Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head. World J Surg. 2006 Aug;30(8):1526–1535
  13. Wang C, Wu H, Xiong J, et al. Pancreaticoduodenectomy with vascular resection for local advanced pancreatic head cancer: a single center retrospective study. J Gastrointest Surg. 2008 Dec;12(12):2183–2190
  14. Wanebo HJ, Glicksman AS, Vezeridis MP, et al. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg. 2000;135:81–87
  15. Mehta VK, Fisher G, Ford JA, et al. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas. J Gastrointest Surg. 2001;5:27–35
  16. Ammori JB, Colleti LM, Zalupski MM, et al. Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas. J Am Med Assoc. 2003;7:768–772
  17. Aristu J, Canon R, Pardo F, et al. Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer. Am J Clin Oncol. 2003;26:30–36
  18. Massucco P, Capussotti L, Magnino A, et al. Locally advanced pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. Ann Surg Oncol. 2006 Sep;13(9):1201–1208
  19. Lind PA, Isaksson B, Almström M, et al. Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma. Acta Oncol. 2008;47(3):413–420
  20. Katz MH, Pisters PW, Evans DB, et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg. 2008 May;206(5):833–846
  21. Crippa S, Domínguez I, Rodríguez JR, et al. Quality of life in pancreatic cancer: analysis by stage and treatment. J Gastrointest Surg. 2008 May;12(5):783–793
  22. Stessin AM, Meyer JE, Sherr DL. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry. Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1128–1133
  23. Moutardier V, Turrini O, Huiart L, et al. A reappraisal of preoperative chemoradiation for localized pancreatic head ductal adenocarcinoma in a 5-year single-institution experience. J Gastrointest Surg. 2004 May-Jun;8(4):502–510
  24. Sa Cunha A, Rault A, Laurent C, et al. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas. J Am Coll Surg. 2005;201:359–365
  25. Ishikawa O, Ohhigashi H, Teshima T, et al. Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreatoduodenal region. J Surg Oncol. 1989;40:143–151
  26. Kim HJ, Czischke K, Brennan MF, et al. Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?. J Gastrointest Surg. 2002;6:763–769
  27. Sasson AR, Wetherington RW, Hoffman JP, et al. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome. Int J Gastrointest Cancer. 2003;34:121–128
  28. White RR, Xie HB, Gottfried MR, et al. Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer. Ann Surg Oncol. 2005;12:214–221
  29. Aloia TA, Lee JE, Vauthey JN, et al. Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy?. J Am Coll Surg. 2007 Mar;204(3):347–355
  30. Snady H, Bruckner H, Cooperman A, et al. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial. Cancer. 2000 Jul 15;89(2):314–327
  31. Kim R, Saif MW. Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer?. JOP. 2007 May 9;8(3):279–288[review]
  32. Moureau-Zabotto L, Phélip JM, Afchain P, et al. Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur Multidisciplinaire en Oncologie Phase II Study. J Clin Oncol. 2008 Mar 1;26(7):1080–1085

PII: S0748-7983(09)00196-6

doi: 10.1016/j.ejso.2009.06.005

European Journal of Surgical Oncology
Volume 35, Issue 12 , Pages 1306-1311 , December 2009

Article Tools

* Image Usage & Resolution